Back to News
Market Impact: 0.22
Investors pour over $30bn into longevity biotech as report predicts longevity drugs from 2035
Source: PR Newswire
Healthcare & BiotechPrivate Markets & VentureCompany Fundamentals
Global investment in longevity biotech reached a record $18.4bn in 2025, nearly quadrupling from $4.7bn in 2024, while $12.1bn has already been invested in 2026. Longevity.Technology forecasts the sector could become a $617bn market by 2045, signaling strong investor interest and long-term growth potential for aging-related biotech.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.55
More News
- Why Wendy’s is losing the burger wars—and is now a takeover target for Nelson Peltz
- Companies promised AI gains— here's how the payoff showed up in earnings
- FBI blames North Korea for record $6.3bn crypto heist
- Binance to resume crypto withdrawals in phases after record $6 billion hack
- AWS grows 39% and Amazon will spend even more on AI in 2027
- SpaceX loses bid to toss NAACP lawsuit over Memphis data center air pollution